DNLI

Denali Therapeutics Inc.NASDAQHealthcare

$20.65+4.93%ClosedMarket Cap: $3.27B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-26	Baird	—	Outperform	—
2026-03-26	HC Wainwright & Co.	—	Buy	—
2026-03-26	Morgan Stanley	—	Overweight	—
2026-03-26	Goldman Sachs	—	Buy	—
2026-03-26	Stifel	—	Buy	—
2026-03-25	BTIG	—	Buy	—
2026-02-06	BTIG	—	Buy	—
2025-12-11	Wedbush	—	Outperform	—
2025-12-05	BTIG	—	Buy	—
2025-11-04	JP Morgan	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-2.49	$136.8M	14
Sun Dec 31	$-0.75	$494.4M	14
Mon Dec 31	$0.14	$689.9M	8
Tue Dec 31	$1.68	$1.06B	12